Coral Halperin

Coral Halperin

Auto-generated profile, based on publicly available information

Coral Halperin

Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2025 in Cancer Discovery
Verified
Journal Article
Closed access
ABAviad Ben-Shmuel
Aviad Ben-Shmuel
YGYael Gruper
Yael Gruper
CHCoral Halperin
Coral Halperin
OLOshrat Levi-Galibov
Oshrat Levi-Galibov
HRHallel Rosenberg-Fogler
Hallel Rosenberg-Fogler
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas. Significance: Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies. See related commentary by Sherman, p. 1096

26 October 2022 in Cancer Research
Verified
Journal Article
Closed access
PDF file
CHCoral Halperin
Coral Halperin
JHJoschka Hey
Joschka Hey
DWDieter Weichenhan
Dieter Weichenhan
YSYaniv Stein
Yaniv Stein
SMShimrit Mayer
Shimrit Mayer
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Cancer cells recruit and rewire normal fibroblasts in their microenvironment to become protumorigenic cancer-associated fibroblasts (CAF). These CAFs are genomically stable, yet their transcriptional programs are distinct from those of their normal counterparts. Transcriptional regulation plays a major role in this reprogramming, but the extent to which epigenetic modifications of DNA also contribute to the rewiring of CAF transcription is not clear. Here we address this question by dissecting the epigenetic landscape of breast CAFs. Applying tagmentation-based whole-genome bisulfite sequencing in a mouse model of breast cancer, we found that fibroblasts undergo massive DNA methylation changes as they transition into CAFs. Transcriptional and epigenetic analyses revealed RUNX1 as a potential mediator of this process and identified a RUNX1-dependent stromal gene signature. Coculture and mouse models showed that both RUNX1 and its stromal signature are induced as normal fibroblasts transition into CAFs. In breast cancer patients, RUNX1 was upregulated in CAFs, and expression of the RUNX1 signature was associated with poor disease outcome, highlighting the relevance of these findings to human disease. This work presents a comprehensive genome-wide map of DNA methylation in CAFs and reveals a previously unknown facet of the dynamic plasticity of the stroma. Significance: The first genome-wide map of DNA methylation in breast cancer–associated fibroblasts unravels a previously unknown facet of the dynamic plasticity of the stroma, with far-reaching therapeutic implications.

9 December 2022 in International Journal of Cancer
Verified
Journal Article
Open access
JHJoschka Hey
Joschka Hey
CHCoral Halperin
Coral Halperin
MHMark Hartmann
Mark Hartmann
SMShimrit Mayer
Shimrit Mayer
MSMaximilian Schönung
Maximilian Schönung
CPChristoph Plass
Christoph Plass
The accumulation of myeloid cells, particularly tumor‐associated macrophages (TAMs), characterizes the tumor microenvironment (TME) of many solid cancers, including breast cancer. Compared to healthy tissue‐resident macrophages, TAMs acquire distinct transcriptomes and tumor‐promoting functions by largely unknown mechanisms. Here, we hypothesize the involvement of TME signaling and subsequent epigenetic reprogramming of TAMs. Using the 4T1 mouse model of triple‐negative breast cancer, we demonstrate that the presence of cancer cells significantly alters the DNA methylation landscape of macrophages and, to a lesser extent, bone marrow‐derived monocytes (BMDMs). TAM methylomes, dissected into BMDM‐originating and TAM‐specific epigenetic programs, implicated transcription factors (TFs) and signaling pathways involved in TAM reprogramming, correlated with cancer‐specific gene expression patterns. Utilizing published single‐cell gene expression data, we linked microenvironmentally‐derived signals to the cancer‐specific DNA methylation landscape of TAMs. These integrative analyses highlighted the role of altered cytokine production in the TME (eg, TGF‐β, IFN‐γ and CSF1) on the induction of specific TFs (eg, FOSL2, STAT1 and RUNX3) responsible for the epigenetic reprogramming of TAMs. DNA methylation deconvolution identified a TAM‐specific signature associated with the identified signaling pathways and TFs, corresponding with severe tumor grade and poor prognosis of breast cancer patients. Similarly, immunosuppressive TAM functions were identified, such as induction of the immune inhibitory receptor‐ligand PD‐L1 by DNA hypomethylation of Cd274. Collectively, these results provide strong evidence that the epigenetic landscapes of macrophages and monocytes are perturbed by the presence of breast cancer, pointing to molecular mechanisms of TAM reprogramming, impacting patient outcomes.

3 June 2025
Verified
Other
Open access
ABAviad Ben-Shmuel
Aviad Ben-Shmuel
YGYael Gruper
Yael Gruper
CHCoral Halperin
Coral Halperin
OLOshrat Levi-Galibov
Oshrat Levi-Galibov
HRHallel Rosenberg-Fogler
Hallel Rosenberg-Fogler
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.Significance:Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies.See related commentary by Sherman, p. 1096

31 March 2023
Verified
Other
Open access
CHCoral Halperin
Coral Halperin
JHJoschka Hey
Joschka Hey
DWDieter Weichenhan
Dieter Weichenhan
YSYaniv Stein
Yaniv Stein
SMShimrit Mayer
Shimrit Mayer
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Cancer cells recruit and rewire normal fibroblasts in their microenvironment to become protumorigenic cancer-associated fibroblasts (CAF). These CAFs are genomically stable, yet their transcriptional programs are distinct from those of their normal counterparts. Transcriptional regulation plays a major role in this reprogramming, but the extent to which epigenetic modifications of DNA also contribute to the rewiring of CAF transcription is not clear. Here we address this question by dissecting the epigenetic landscape of breast CAFs. Applying tagmentation-based whole-genome bisulfite sequencing in a mouse model of breast cancer, we found that fibroblasts undergo massive DNA methylation changes as they transition into CAFs. Transcriptional and epigenetic analyses revealed RUNX1 as a potential mediator of this process and identified a RUNX1-dependent stromal gene signature. Coculture and mouse models showed that both RUNX1 and its stromal signature are induced as normal fibroblasts transition into CAFs. In breast cancer patients, RUNX1 was upregulated in CAFs, and expression of the RUNX1 signature was associated with poor disease outcome, highlighting the relevance of these findings to human disease. This work presents a comprehensive genome-wide map of DNA methylation in CAFs and reveals a previously unknown facet of the dynamic plasticity of the stroma.Significance:The first genome-wide map of DNA methylation in breast cancer–associated fibroblasts unravels a previously unknown facet of the dynamic plasticity of the stroma, with far-reaching therapeutic implications.

31 March 2023
Verified
Other
Open access
CHCoral Halperin
Coral Halperin
JHJoschka Hey
Joschka Hey
DWDieter Weichenhan
Dieter Weichenhan
YSYaniv Stein
Yaniv Stein
SMShimrit Mayer
Shimrit Mayer
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Supplementary Table from Global DNA Methylation Analysis of Cancer-Associated Fibroblasts Reveals Extensive Epigenetic Rewiring Linked with RUNX1 Upregulation in Breast Cancer Stroma